"clinical outcomes according" trang 8 - tải miễn phí từ tailieunhanh
Predicting clinical outcomes in chordoma patients receiving immunotherapy: A comparison between volumetric segmentation and RECIST

Predicting clinical outcomes in chordoma patients receiving immunotherapy: A comparison between volumetric segmentation and RECIST
9    47    1
MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer

MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer
12    60    1
Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients

Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients
7    53    1
Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and nonoropharyngeal patients

Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and nonoropharyngeal patients
13    43    1
The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer

The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer
9    70    1
Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma

Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma
9    71    1
Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?

Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?
9    41    1
The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy

The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy
9    46    2
Gynecological hysterectomy in Northern Tanzania: A cross - sectional study on the outcomes and correlation between clinical and histological diagnoses

Gynecological hysterectomy in Northern Tanzania: A cross - sectional study on the outcomes and correlation between clinical and histological diagnoses
8    29    1
Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers

Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers
13    40    1
Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer

Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer
8    50    1
Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults

Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults
10    64    1
A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatments

A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatments
7    38    1
MicroRNA-21 and the clinical outcomes of various carcinomas: A systematic review and meta-analysis

MicroRNA-21 and the clinical outcomes of various carcinomas: A systematic review and meta-analysis
11    67    1
High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer

High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer
12    70    1
Predicting clinically promising therapeutic hypotheses using tensor factorization

Predicting clinically promising therapeutic hypotheses using tensor factorization
12    49    1
Exploration of the psychometric properties of the clinical outcomes in routine evaluation-outcome measure in ecuador

Exploration of the psychometric properties of the clinical outcomes in routine evaluation-outcome measure in ecuador
11    50    3
Total knee arthroplasty according to the original knee phenotypes with kinematic alignment surgical technique-early clinical and functional outcomes

Total knee arthroplasty according to the original knee phenotypes with kinematic alignment surgical technique-early clinical and functional outcomes
10    52    1
Comparison of the clinical outcomes of percutaneous vertebroplasty vs. kyphoplasty for the treatment of osteoporotic Kümmell’s disease: A prospective cohort study

Comparison of the clinical outcomes of percutaneous vertebroplasty vs. kyphoplasty for the treatment of osteoporotic Kümmell’s disease: A prospective cohort study
8    37    1
Complications to 6 months following total hip or knee arthroplasty: Observations from an Australian clinical outcomes registry

Complications to 6 months following total hip or knee arthroplasty: Observations from an Australian clinical outcomes registry
11    43    1